News

The Ramsell 340B solution combines pharmacy management services such as claims adjudication and utilization reporting, along with a platform that provides specific features to manage and track 340B

The company claims that ELN provides numerous benefits beyond eliminating paper lab notebooks. The open architecture is designed to simplify and accelerate the R&D process by streamlining data

As per the agreement, Cordis will receive $1.725 billion from Boston Scientific and Johnson & Johnson expects to record the majority of this payment as a special item

The partnership will initially focus on integrating ImageWare’s patented biometric solution into Vista LifeSciences’ STAT Medical Jacket, the intelligent electronic medical record used to hold all of a

Under the terms of the agreement, Lilly will fund a collaborative research and development program with the aim of creating improved drugs incorporating SPL’s proprietary delivery technology, and

The Establishment License issued by Health Canada will enable Dalton to continue to manufacture, test and ship sterile commercial products for its existing clients. In addition, Dalton’s solid

In accordance with the Scheme, all Scheme shares have been transferred to YM and Cytopia is now a wholly-owned subsidiary of YM. The Scheme Consideration, as well as

Bernardo Gradin, CEO of Braskem, said: “The acquisition of Sunoco Chemicals provides Braskem with a solid and competitive platform for growth in the world’s biggest market, which will

Luliconazole is a potent and broad-spectrum topical antifungal agent in development and will be advancing to phase 3 clinical development in the US for tinea pedis (athlete’s foot).